Cibus (CBUS) EBT Margin (2016 - 2026)
Cibus (CBUS) posted EBT Margin of 3021.95% for Q4 2025, up 23.55% sequentially from 3952.68% in Q3 2025, and down 89340.0% YoY from N/an in Q4 2024.
Cibus (CBUS) EBT Margin (2016 - 2026) Analysis & Trends
Cibus has reported EBT Margin for 10 years, with the latest figure at 3021.95% in Q4 2025.
- Quarterly EBT Margin fell 89340.0% year-over-year to 3021.95% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 3632.1% (up 300056.0% YoY) and the FY2025 annual result came in at 3632.1%, up 300056.0% from the prior year.
- EBT Margin grew to 3021.95% in Q4 2025 per CBUS's latest filing, from 3952.68% in the prior quarter.
- Over five years, EBT Margin peaked at 40.46% in Q2 2021 and troughed at 25132.55% in Q4 2023.
- A 5-year average of 6903.77% and a median of 4861.51% in 2024 frame the typical range for EBT Margin.
- The sharpest annual moves came in 2023 and 2024: EBT Margin plunged 1837779 bps in 2023, then soared 2300400 bps in 2024.
- Over 5 years, EBT Margin stood at 363.2% in 2021, then tumbled by 1760 bps to 6754.76% in 2022, then plunged by 272 bps to 25132.55% in 2023, then soared by 92 bps to 2128.55% in 2024, then tumbled by 42 bps to 3021.95% in 2025.
- According to Business Quant data, EBT Margin over the past three periods registered 3021.95%, 3952.68%, and 2843.62% for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 35.71% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -528.97% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 18.33% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 13.77% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -2.67% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 12.09% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -25.06% |
| 10 | Cibus | 131.25 Mn | 110.82 Mn | - | -2,227.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2,227.26% |
| Dec 31, 2025 | -3,021.95% |
| Sep 30, 2025 | -3,952.68% |
| Jun 30, 2025 | -2,843.62% |
| Mar 31, 2025 | -4,776.60% |
| Dec 31, 2024 | -2,128.55% |
| Sep 30, 2024 | -12,084.34% |
| Jun 30, 2024 | -3,398.81% |
| Mar 31, 2024 | -4,946.42% |
| Dec 31, 2023 | -25,132.55% |
| Sep 30, 2023 | -7,269.05% |
| Jun 30, 2023 | -10,410.66% |
| Mar 31, 2023 | -12,842.86% |
| Dec 31, 2022 | -6,754.76% |
| Sep 30, 2022 | -14,166.67% |
| Jun 30, 2022 | -6,060.98% |
| Mar 31, 2022 | -17,559.38% |
| Dec 31, 2021 | -363.20% |
| Sep 30, 2021 | -94.14% |
| Jun 30, 2021 | -40.46% |